Fund shareholders of Revolution Medicines Inc
ISIN US76155X1000 · United States · LEI 549300JU3X0LBCQ65892
- Fund shareholders
- 420
- Of which ETFs
- 98 322 other funds
- Value held
- 5.1B $ 404.1M SEK · 677.8K €
- Share of capital
- 22.6 % of 214.3M shares on Jul 31, 2026
This issuer has other securities : REVOLUTION MEDICINES INC WTS 12/26 (US76155X1182)
420 funds hold this company. This table lists the 419 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| The U.S. Equity Portfolio HC Capital Trust | 3,305 | 321.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT LARGE CAP INDEX FUND SEI INSTITUTIONAL MANAGED TRUST | 3,250 | 316.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SPP Generation 60-tal Storebrand Asset Management AS | 3,234 | 3M SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Mid Cap Value Fund Penn Series Funds Inc | 3,209 | 312.1K $ | 0.36 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 3,139 | 320.2K $ | 1.13 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 3,109 | 302.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TCW Transform 500 ETF TCW ETF Trust | 3,092 | 445.6K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Lannebo Marknad Global Lannebo Kapitalförvaltning AB | 3,000 | 2.8M SEK | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 2,964 | 288.2K $ | 0.49 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,954 | 287.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Sustainable Aware Advantage Large Cap Core Fund BlackRock Funds | 2,820 | 287.7K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Column Mid Cap Fund Trust for Professional Managers | 2,789 | 284.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 2,767 | 269.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Skandia Nordamerika Exponering Skandia Fonder AB | 2,700 | 2.5M SEK | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 2,670 | 384.8K $ | 1.50 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Calvert US Large-Cap Core Responsible Index ETF Morgan Stanley ETF Trust | 2,587 | 251.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MidCap Value Fund I Principal Funds, Inc | 2,523 | 363.6K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 2,500 | 243.1K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LargeCap Value Fund III Principal Funds, Inc | 2,477 | 357K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 2,392 | 344.7K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 2,331 | 226.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Value Equity ETF Goldman Sachs ETF Trust | 2,226 | 227.1K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP JPMorgan Select Mid Cap Value Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,214 | 215.3K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 2,144 | 208.5K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 2,000 | 204K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 1,871 | 182K $ | 1.71 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Eventide US Market ETF Strategy Shares | 1,764 | 254.2K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Guardian Mid Cap Traditional Growth VIP Fund Guardian Variable Products Trust | 1,748 | 170K $ | 0.47 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 1,700 | 245K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Franklin DynaTech VIP Fund Franklin Templeton Variable Insurance Products Trust | 1,677 | 163.1K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Atlantic Wellington Research Managed Risk Portfolio Forethought Variable Insurance Trust | 1,601 | 155.7K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Value ETF Columbia ETF Trust I | 1,510 | 217.6K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,500 | 145.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ALGER MID CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 1,463 | 210.8K $ | 0.39 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Core Portfolio Forethought Variable Insurance Trust | 1,457 | 141.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Calvert US Mid-Cap Core Responsible Index ETF Morgan Stanley ETF Trust | 1,448 | 140.8K $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Global Atlantic BlackRock Disciplined Value Portfolio Forethought Variable Insurance Trust | 1,389 | 135.1K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| John Hancock Multifactor Large Cap ETF John Hancock Exchange-Traded Fund Trust | 1,319 | 128.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Xtrackers MSCI Kokusai Equity ETF DBX ETF Trust | 1,310 | 133.6K $ | 0.02 % | 0.00 % | as of Feb 27, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,276 | 124.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,271 | 129.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Hedged Equity Fund Fidelity Greenwood Street Trust | 1,254 | 180.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,163 | 113.1K $ | 0.59 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Future Health Care Equity ETF Goldman Sachs ETF Trust | 1,159 | 118.2K $ | 0.52 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD WELLINGTON U.S. GROWTH ACTIVE ETF VANGUARD WELLESLEY INCOME FUND | 1,118 | 108.7K $ | 0.47 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 1,056 | 102.7K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 1,050 | 102.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 1,044 | 101.5K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 1,010 | 145.6K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,002 | 97.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lannebo Marknad USA Lannebo Kapitalförvaltning AB | 1,000 | 926.4K SEK | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,000 | 97.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 997 | 143.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF PIMCO Equity Series | 979 | 95.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 956 | 97.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 920 | 132.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 909 | 88.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 889 | 86.5K $ | 0.57 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AVIP AB Mid Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 850 | 82.7K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 836 | 120.5K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 822 | 79.9K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 782 | 76K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 764 | 110.1K $ | 1.35 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SPP Generation 80-tal Storebrand Asset Management AS | 754 | 698.5K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 747 | 72.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 723 | 104.2K $ | 1.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 722 | 70.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 625 | 90.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 609 | 59.2K $ | 0.47 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL MSCI Global Equity Index Fund Allianz Variable Insurance Products Trust | 602 | 58.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Large Cap Value V.I. Fund BlackRock Variable Series Funds, Inc. | 597 | 58.1K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SPP Generation 50-tal Storebrand Asset Management AS | 584 | 541K SEK | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GuideMark Small/Mid Cap Core Fund GPS Funds I | 516 | 50.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 504 | 49K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Kokusai ETF iShares Trust | 494 | 71.2K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Large Cap Core V.I. Fund BlackRock Variable Series Funds, Inc. | 493 | 47.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 491 | 70.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Large Cap Core Portfolio BlackRock Series Fund, Inc. | 463 | 45K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 451 | 46K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 424 | 41.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Allocation: Aggressive Fund American Century Strategic Asset Allocations Inc | 398 | 57.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 398 | 40.6K $ | 0.45 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 387 | 39.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| BNY Mellon Mid Cap Multi-Strategy Fund BNY MELLON FUNDS TRUST | 375 | 38.3K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Core Market Fund SA FUNDS INVESTMENT TRUST | 337 | 32.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Simplify Next Intangible Core Index ETF Simplify Exchange Traded Funds | 327 | 31.8K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 315 | 45.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SEB Global Exposure SEB Funds AB | 269 | 249.2K SEK | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AB Dynamic Asset Allocation Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 265 | 25.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Comstock Capital Value Fund Comstock Funds, Inc. | 250 | 24.3K $ | 0.24 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 245 | 23.8K $ | 0.32 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SPP Generation 40-tal Storebrand Asset Management AS | 238 | 220.5K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 229 | 33K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Virtus Silvant Small/Mid Growth ETF Virtus ETF Trust II | 220 | 31.7K $ | 1.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 209 | 30.1K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 209 | 20.3K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 208 | 20.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 153 | 14.9K $ | 0.66 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 146 | 14.9K $ | 0.17 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Hartford Schroders Diversified Opportunities Fund HARTFORD MUTUAL FUNDS II, INC | 136 | 19.6K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 6.85 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 6.29 % | as of Feb 28, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 4.13 % | as of Mar 31, 2026 ↗ |
| Marsico Midcap Growth Focus Fund MARSICO INVESTMENT FUND | 3.22 % | as of Mar 31, 2026 ↗ |
| Pinnacle Focused Opportunities ETF Tidal Trust II | 3.15 % | as of Feb 28, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.98 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 2.86 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.82 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Transformational Growth ETF Janus Detroit Street Trust | 2.41 % | as of Apr 30, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 2.38 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 400 | +41 | 47,949,343 | -6.1 % |
| 2026Q1 | 359 | +41 | 51,041,234 | -8.6 % |
| 2025Q4 | 318 | -18 | 55,857,845 | -6.5 % |
| 2025Q3 | 336 | +10 | 59,732,762 | -7.8 % |
| 2025Q2 | 326 | +4 | 64,794,405 | +3.7 % |
| 2025Q1 | 322 | +9 | 62,505,392 | +5.6 % |
| 2024Q4 | 313 | +26 | 59,209,688 | +5.5 % |
| 2024Q3 | 287 | +20 | 56,129,869 | +4.9 % |
| 2024Q2 | 267 | +18 | 53,490,879 | +17.6 % |
| 2024Q1 | 249 | +26 | 45,498,077 | +12.7 % |
| 2023Q4 | 223 | 40,365,735 |
Institutional managers
503 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13,604,796 | 1.3B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 11,212,706 | 1.1B $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 9,766,496 | 949.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 9,555,357 | 929.3M $ | as of Mar 31, 2026 |
| FMR LLC | 8,464,314 | 823.2M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,601,087 | 739.2M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 6,655,703 | 647.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,027,819 | 586.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,475,611 | 532.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,402,662 | 428.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,386,791 | 426.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,338,142 | 323.9M $ | as of Mar 31, 2026 |
| Alphabet Inc. | 3,292,525 | 320.2M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,232,213 | 314.3K $ | as of Mar 31, 2026 |
| BVF INC/IL | 2,856,782 | 277.8M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 2,577,333 | 250.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 2,506,570 | 243.8M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 2,468,644 | 240.1M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,375,000 | 231M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,344,444 | 228M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,297,000 | 223.4M $ | as of Mar 31, 2026 |
| Darwin Global Management, Ltd. | 2,211,018 | 205M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,185,500 | 212.5M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,000,000 | 194.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,885,821 | 183.4M $ | as of Mar 31, 2026 |
Declared shareholders of Revolution Medicines Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.90 % | 9,766,496 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Revolution Medicines Inc
12 funds declare 12 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| NYLI MacKay Convertible Fund | 1 | 18.9M $ | as of Apr 30, 2026 |
| Calamos Growth & Income Fund | 1 | 12.3M $ | as of Apr 30, 2026 |
| Calamos Market Neutral Income Fund | 1 | 6M $ | as of Apr 30, 2026 |
| Calamos Convertible Fund | 1 | 5M $ | as of Apr 30, 2026 |
| Putnam Convertible Securities Fund | 1 | 4.6M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 3.3M $ | as of Apr 30, 2026 |
| Calamos Global Opportunities Fund | 1 | 1.6M $ | as of Apr 30, 2026 |
| Miller Market Neutral Income Fund | 1 | 753K $ | as of Apr 30, 2026 |
| First Trust SSI Strategic Convertible Securities ETF | 1 | 568.2K $ | as of Apr 30, 2026 |
| Calamos Global Convertible Fund | 1 | 402K $ | as of Apr 30, 2026 |
| Janus Henderson Income ETF | 1 | 344.5K $ | as of Apr 30, 2026 |
| Miller Convertible Total Return ETF | 1 | 55.8K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Revolution Medicines Inc". https://titelia.com/en/stocks/revolution-medicines-inc-US76155X1000